Company: NBRG
Filing Date: 2025-07-28
Form Type: DRS/A
Source: 0001213900-25-068218
Chunk: 188

Company: Newbridge Acquisition Ltd
Filing Date: 2025-07-28
Form: DRS/A
Chunk 188
---
 account. Immediate after this offering, assuming the over -allotmentoption is not exercised, an aggregate of 175,000 private units (or 186,250 units if the over -allotmentoption is exercised in full), at a price of $10.00 per unit for an aggregate purchase price of 1,750,000 (or 1,862,500 if the over -allotmentoption is exercised in full)in a private placement that will close simultaneously with the closing of this offering. In addition, if our sponsor makes any working capital loans, up to $1,500,000 of such loans may be converted into units, at the price of $10.00 per unit at the option of the lender. Such units would be identical to the private units. To the extent we issue ordinary shares to effectuate a business combination transaction, the potential for the issuance of a substantial number of additional ordinary shares upon conversion of these rights or conversion of these working capital loans into our securities could make us a less attractive acquisition vehicle to a target business. Any such issuance will increase the number of issued and outstanding ordinary shares and reduce the value of the ordinary shares issued to complete the business combination transaction. Therefore, our rights and founder shares may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business. See the Section entitled “Dilution” of this prospectus for additional information. We may reimburse our sponsor, officers, directors or any of their affiliates for out -of -pocketexpenses incurred in connection with certain activities on our behalf, such as identifying and investigating possible business targets and business combinations. There is no limit on the amount of out -of -pocketexpenses reimbursable by us provided that, to the extent such expenses exceed the available proceeds not deposited in the trust account, such expenses would not be reimbursed by us unless we consummate an initial business combination. Our audit committee will review and approve all reimbursements and payments made to the sponsor or member of our management team, or our or their respective affiliates, and any reimbursements and payments made to members of our audit committee will be reviewed and approved by our board of directors, with any interested director abstaining from such review and approval. Each of our directors, director nominees and officers presently has and any of them in the future may have additional, fiduciary or contractual obligations to other entities, pursuant to which such officer or director is or will be required to present a business combination opportunity. Accordingly,